Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies

Brain

Volumn 120, Issue 9, 1997, Pages 1513-1531

  Slater, C R ^a,d   Young, C ^a   Wood, S J ^a,e   Bewick, G S ^a,f   Anderson, L V B ^a   Baxter, P ^a,g   Fawcett, P R W ^a   Roberts, M ^b,h   Jacobson, L ^b   Kuks, J ^c   Vincent, A ^b   Newsom Davis, J ^b  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

^g SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^h WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Acetylcholine receptor; Congenital myasthenic syndrome; Myasthenia gravis; Neuromuscular junction; Utrophin

Indexed keywords

CHOLINERGIC RECEPTOR; CYTOPLASM PROTEIN; DYSTROPHIN; SPECTRIN; UTROPHIN;

ADULT; ARTICLE; CASE REPORT; CHILD; FEMALE; HUMAN; HUMAN TISSUE; MALE; MINIATURE ENDPLATE POTENTIAL; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; SCHOOL CHILD;

ACTION POTENTIALS; ADULT; CHILD; CYTOSKELETAL PROTEINS; ELECTROPHYSIOLOGY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MOTOR ENDPLATE; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; RECEPTORS, CHOLINERGIC; SYNAPTIC TRANSMISSION; UTROPHIN;

EID: 0030763983     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.9.1513     Document Type: Article

References (63)

1. Apel ED, Roberds SL, Campbell KP, Merlie JP. Rapsyn may function as a link between the acetylcholine receptor and the agrinbinding dystrophin-associated glycoprotein complex. Neuron 1995; 15: 115-26.
2. Arizono N, Koreto O, Iwai Y, Hidaka T, Takeoka O. Morphometric analysis of human neuromuscular junction in different ages. Acta Pathol Japon 1984; 34: 1243-9.
3. Beeson D, Amar M, Bermudez I, Vincent A, Newsom-Davis J. Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the ε subunit. Neurosci Letts 1996; 207: 57-60.
4. Bewick GS, Nicholson LV, Young C, O'Donnell E, Slater CR. Different distributions of dystrophin and related proteins at nerve-muscle junctions. Neuroreport 1992; 3: 857-60.
5. Bewick GS, Nicholson LV, Young C, Slater CR. Relationship of a dystrophin-associated glycoprotein to junctional acetylcholine receptor clusters in rat skeletal muscle. Neuromuscul Disord 1993; 3: 503-6.
6. Bewick GS, Young C, Slater CR. Spatial relationships of utrophin, dystrophin, β-dystroglycan and β-spectrin to acetylcholine receptor clusters during postnatal maturation of the rat neuromuscular junction. J Neurocytol 1996; 25: 367-79.
7. Bloch RJ, Morrow JS. An unusual β-spectrin associated with clustered, acetylcholine receptors. J Cell Biol 1989; 108: 481-93.
8. Bloch RJ, Pumplin DW. Molecular events in synaptogenesis: nerve-muscle adhesion and postsynaptic differentiation. [Review]. Am J Physiol 1988; 254: C345-64.
9. Brown MC, Holland RL, Hopkins WG. Motor nerve sprouting. [Review]. Annu Rev Neurosci 1981; 4: 17-42.
10. Coërs C, Woolf AL. The innervation of muscle. Oxford: Blackwell, 1959.
11. Deconinck AE, Potter AC, Tinsley JM, Wood SJ, Vater R, Young C, et al. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol 1997; 136: 883-94.
12. Drachman DB. Myasthenia gravis. [Review]. N Engl J Med 1994; 330: 1797-810.
13. Duchen LW, Strich SJ. The effects of botulinum toxin on the pattern of innervation of skeletal muscle in the mouse. Q J Exp Physiol Cogn Med Sci1968; 53: 84-9.
14. Engel AG, Santa T. Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann N Y Acad Sci 1971; 183: 46-63.
15. Engel AG, Lambert EH, Howard FM. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 1977; 52: 267-80.
16. Engel AG, Lambert EH, Mulder DM, Torres CF, Sahashi K, Bertorini TE, et al. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol 1982; 11: 553-69.
17. Engel AG, Walls TJ, Nagel A, Uchitel O. Newly recognized congenital myasthenic syndromes: I. Congenital paucity of synaptic vesicles and reduced quantal release. II. High-conductance fast-channel syndrome. III. Abnormal acetylcholine receptor (AChR) interaction with acetylcholine. IV. AChR deficiency and short channel-open time. Prog Brain Res 1990; 84: 125-37.
18. Fawcett PRW, Slater CR, Baxter P, Young C, Walls TJ, Gardner-Medwin D, et al. Congenital myasthenia with reduction of utrophin and acetylcholine receptors at the neuromuscular junction [abstract]. Electroencephalogr Clin Neurophysiol 1994; 91: 100P.
19. + channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and 43 kd protein. Neuron 1989; 3: 163-75.
20. Froehner SC. Regulation of ion channel distribution at synapses. [Review]. Ann Rev Neurosci 1993; 16: 347-68.
21. Froehner SC, Gulbrandsen V, Hyman C, Jeng AY, Neubig RR, Cohen JB. Immunofluorescence localization at the mammalian neuromuscular junction of the Mr 43,000 protein of Torpedo postsynaptic membranes. Proc Natl Acad Sci USA 1981; 78: 5230-4.
22. Gautam M, Noakes PG, Mudd J, Nichol M, Chu GC, Sanes JR, et al. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice [see comments]. Nature 1995; 377: 232-6. Comment in: Nature 1995; 377: 195-6.
23. Grady RM, Merlie JP, Sanes JR. Subtle neuromuscular defects in utrophin-deficient mice. J Cell Biol 1997; 136: 871-82.
24. Hall ZW, Sanes JR. Synaptic structure and development: the neuromuscular junction. [Review]. Cell 1993; 72 Suppl: 99-121.
25. Hoffman EP, Kunkel LM. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. [Review]. Neuron 1989; 2: 1019-29.
26. Holland RL, Brown MC. Postsynaptic transmission block can cause terminal sprouting of a motor nerve. Science 1980; 207: 649-51.
27. Ito Y, Miledi R, Vincent A, Newsom-Davis J. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis. Brain 1978; 101: 345-68.
28. Karnovsky MJ, Roots L. A 'direct coloring' thiocholine method for cholinesterases. J Histochem Cytochem 1964; 12: 219-21.
29. Liley AW. An investigation of spontaneous activity at the neuromuscular junction of the rat. J Physiol (Lond) 1956; 132: 650-66.
30. Love DR, Hill DF, Dickson G, Spurr NK, Byth BC, Marsden RF, et al. An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 1989; 339: 55-8.
31. Lyons PR, Slater CR. Structure and function of the neuromuscular junction in young adult mdx mice. J Neurocytol 1991; 20: 969-81.
32. Marsh D, Grassi J, Vigny M, Massoulié J. An immunological study of rat acetylcholinesterase: comparison with acetylcholinesterases from other vertebrates. J Neurochem 1984; 43: 204-13.
33. Martin AR. Amplification of neuromuscular transmission by postjunctional folds. Proc Roy Soc Lond B Biol Sci 1994; 258: 321-6.
34. Maselli RA, Mass DP, Distad BJ, Richman DP. Anconeus muscle: a human muscle preparation suitable for in-vitro microelectrode studies. Muscle Nerve 1991; 14: 1189-92.
35. McLachlan EM. The statistics of transmitter release at chemical synapses. Int Rev Physiol 1978; 17: 49-117.
36. Morgan-Hughes JA, Lecky BRF, Landon DN, Murray NMF. Alterations in the number and affinity of junctional acetylcholine receptors in a myopathy with tubular aggregates. A newly recognized receptor defect. Brain 1981; 104: 279-95.
37. Morris A, Beeson D, Jacobson L, Baggi F, Vincent A, Newsom-Davis J. Two isoforms of the muscle acetylcholine receptor alpha-subunit are translated in the human cell line TE671. FEBS Lett 1991; 295: 116-8.
38. Nguyen TM, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, et al. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 1991; 115: 1695-700.
39. Nicholson LVB, Davison K, Falkous G, Harwood C, O'Donnell E, Slater CR, et al. Dystrophin in skeletal muscle I. Western blot analysis using a monoclonal antibody. J Neurol Sci 1989; 94: 125-36.
40. Nicholson LVB, Johnson MA, Davison K, O'Donnell E, Falkous G, Barron M, et al. Dystrophin or a 'related protein' in Duchenne muscular dystrophy? Acta Neurol Scand 1992; 86: 8-14.
41. Noakes PG, Phillips WD, Hanley TA, Sanes JR, Merlie JP. 43K protein and acetylcholine receptors colocalize during the initial stages of neuromuscular synapse formation in vivo. Dev Biol 1993; 155: 275-80.
42. Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 1991; 7: 499-508.
43. Phillips WD, Noakes PG, Roberds SL, Campbell KP, Merlie JP. Clustering and immobilization of acetylcholine receptors by the 43-kD protein: a possible role for dystrophin-related protein. J Cell Biol 1993; 123: 729-40.
44. Plomp JJ, Van Kempen GT, De Baets MB, Graus YM, Kuks JB, Molenaar PC. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Ann Neurol 1995; 37: 627-36.
45. Salpeter MM. Vertebrate neuromuscular junctions: general morphology, molecular organization, and functional consequences. In: Salpeter MM, editor. The vertebrate neuromuscular junction. New York: Alan R. Liss, 1987: 1-54.
46. Sanes JR, Cheney JM. Lectin binding reveals a synapse-specific carbohydrate in skeletal muscle. Nature 1982; 300: 646-7.
47. Sealock R, Butler MH, Kramarcy NR, Gao KX, Murnane AA, Douville K, et al. Localization of dystrophin relative to acetylcholine receptor domains in electric tissue and adult and cultured skeletal muscle. J Cell Biol 1991; 113: 1133-44.
48. Shillito P, Vincent A, Newsom-Davis J. Congenital myasthenic syndromes. [Review]. Neuromuscul Disord 1993; 3: 183-90.
49. Slater CR, Lyons PR, Walls TJ, Fawcett PR, Young C. Structure and function of neuromuscular junctions in the vastus lateralis of man. A motor point biopsy study of two groups of patients. Brain 1992; 115: 451-78.
50. Slater CR, Young C, Wood SJ, Nicholson LVB, Bewick GS, Baxter P, et al. Reduction of utrophin associated with acetylcholine receptor deficiency at the neuromuscular junction in human diseases [abstract]. J Cellular Biochem 1994; Suppl 18D: 541.
51. Slater CR, Fawcett PRW, Gardner-Medwin D, Lyons PR, Walls TJ, Wood SJ, et al. Defects of the neuromuscular junction associated with impaired neuromuscular transmission in limb-girdle myasthenias in man. J Physiol (Lond) 1995; 489.P: 150P-151P.
52. Smit LM, Veldman H, Jennekens FG, Molenaar PC, Oen BS. A congenital myasthenic disorder with paucity of secondary synaptic clefts: deficiency and altered distribution of acetylcholine receptors. Ann N Y Acad Sci 1987; 505: 346-56.
53. Srinivasan Y, Elmer L, Davis J, Bennett V, Angelides K. Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature 1988; 333: 177-80.
54. Tinsley JM, Blake DJ, Roche A, Fairbrother U, Riss J, Byth BC, et al. Primary structure of dystrophin-related protein. Nature 1992; 360: 591-3.
55. Tinsley JM, Blake DJ, Zuellig RA, Davies KE. Increasing complexity of the dystrophin-associated protein complex. [Review]. Proc Natl Acad Sci USA 1994; 91: 8307-13.
56. Unwin N. Nicotinic acetylcholine receptor at 9 Å resolution. J Mol Biol 1993; 229: 1101-24.
57. Vautrin J, Mambrini J. Synaptic current between neuromuscular junction folds. J Theor Biol 1989; 140: 479-98.
58. Vincent A, Cull-Candy SG, Newsom-Davis J, Trautmann A, Molenaar PC, Polak RL. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases. Muscle Nerve 1981; 4: 306-18.
59. Vincent A, Newsom-Davis J, Wray D, Shillito P, Harrison J, Betty M, et al. Clinical and experimental observations in patients with congenital myasthenic syndromes. Ann N Y Acad Sci 1993; 681: 451-60.
60. Vincent A, Newland C, Croxen R, Beeson D. Genes at the junction-candidates for congenital myasthenic syndromes. Trends Neurosci 1997; 20: 15-22.
61. Wokke JH, Jennekens FG, van den Oord CJ, Veldman H, Smit LM, Leppink GJ. Morphological changes in the human end plate with age. J Neurol Sci 1990; 95: 291-310.
62. Wood SJ, Slater CR. Action potential generation in rat slow- and fast-twitch muscles. J Physiol (Lond) 1995; 486: 401-10.
63. Wood SJ, Slater CR. The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles. J Physiol (Lond) 1997; 500: 165-76.